Back to Search Start Over

Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology

Source :
Plus Company Updates. December 21, 2023
Publication Year :
2023

Abstract

SOUTH SAN FRANCISCO: Enable Biosciences Inc has issued the following news release: Enable Biosciences Inc., a leader in diagnostic technologies, is elated to announce its receipt of a Phase IIB [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.777358088